Antibacterial Agents TRIZ Cases

Using conserved PhtX antigens resolves the trade-off between narrow serotype protection and broad vaccine coverage for pneumococcal disease.

Attenuated Salmonella vectors expressing Chlamydial antigens resolve vaccine safety and effectiveness trade-offs.

Salicylic acid composition inhibits E. coli adhesion and growth through multi-target mechanisms.

Inhibitor compounds mimic host carbohydrate receptors to prevent bacterial colonization, avoiding antibiotic resistance risks.

Ultrasonic-assisted water extraction and alcohol precipitation isolate high-purity Cordyceps militaris polysaccharides while maintaining biological activity.

A multivalent pneumococcal conjugate composition utilizes CRM197 and tetanus toxoid carriers to enhance antibody responses.

Pyridinium ionic liquid catalyzes a one-pot synthesis of antimicrobial imidazoles, eliminating hazardous solvents to reduce environmental impact.

Copper-mediated click chemistry simplifies complex synthesis by enabling efficient ligand conjugation to oligonucleotides.

Citric acid or thioglycerol antioxidants prevent oxidative degradation of aqueous pradofloxacin solutions, ensuring stable injectable readiness.

Ophthalmic oil-in-water emulsions maintain positive zeta potential by removing phospholipids, preventing droplet coalescence and toxic side effects.

Bacteriophage ΦCJ7 eliminates antibiotic resistance risks by targeting Salmonella surface receptors without harming beneficial gut flora.

Combining L. johnsonii La1 and B. longum NCC2705 overcomes single-strain limitations by significantly up-regulating hBD1 and hBD2 expression.

Synthetic phosphorylated hexaacyl disaccharides replace toxic lipopolysaccharide sources to provide safe, uniform immunotherapeutics.

Sulfonated dendrimers prevent conjunctivitis spread and minimize bacterial resistance without unnecessary antibiotic use.

Lactic acid bacteria compositions treat diarrhea in newborn animals by restoring intestinal flora balance, avoiding antibiotic resistance.

Composite phosphors convert deep-penetrating x-rays into light, activating drugs at the tumor site without invasive procedures.

Non-lipidated ORF2086 polypeptides resolve expression challenges to elicit bactericidal antibodies against Neisseria meningitidis serogroups.

A tetrahydroquinoline compound combines pyridine and coumarin motifs to deliver broad-spectrum antimicrobial activity.

Optimized Nanobody sequences improve therapeutic efficacy by balancing high affinity with reduced immunogenicity through parameter changes.

Substituted urea depsipeptide analogs activate the bacterial ClpP endopeptidase to force dormant persister cells within biofilms into self-digestion.

Solid water-soluble fiber carriers disintegrate upon eye contact, ensuring accurate dosing and reliable corneal retention without precise administration.

VISTA blockade reverses tumor microenvironment suppression to overcome limited response rates in cancer immunotherapy.

A silver oxide formulation uses irregular macrocrystals to enhance antimicrobial efficacy.

Recombinant alpha-1 antitrypsin fusion molecules link the protein to immunoglobulin fragments, achieving 1000-fold potency gains over plasma-derived sources.

Thiamine derivatives reduce oxidative stress and TNFα levels, improving survival rates before pathogen identification.

Stabilized beta-hairpin peptidomimetics overcome bacterial resistance in Gram-negative infections while reducing host cell cytotoxicity.

Outer membrane vesicle vaccine consortium induces humoral and cell-mediated immune responses.

Fusing CD40 with inducible Pattern Recognition Receptor adapters activates dendritic cells, overcoming migration limits and immunosuppression.

Hydrocarbon-stapled peptides overcome antibiotic resistance by selectively disrupting bacterial membranes while minimizing mammalian cytotoxicity.

Humanized antibodies neutralize pertussis toxin protein, resolving the failure of conventional antibiotics to eliminate bacterial toxins.

Succinate buffer stabilizes multiple antibodies in coformulations, preventing degradation during long-term storage.

Derivatization prevents cell penetration, avoiding calcineurin inhibition and immunosuppressive side effects.

Oligosaccharide conjugates mimic PNAG antigens to induce protective antibody titers against Staphylococcus aureus infections.

Electroporation delivery of codon-optimized DNA vaccines overcomes inadequate protection against Clostridium difficile toxins A and B.

Targeting autocatalytic protease centers with specific antibodies prevents intestinal flora disruption and antibiotic resistance.

Replacing toxic phenol with aliphatic acid and amine solvents eliminates health risks while maintaining high extraction yields for safe medical use.

An attenuated Salmonella carrier presents diverse Streptococcus pneumoniae antigens, overcoming limited serotype coverage in young children.

Targeted antigens and antibodies detect multiresistant Enterococcus strains, enabling precise infection control.

A hydrogel combining galactomannan and N-acetyl cysteine delivers synergistic antioxidant protection for skin repair.

Combining LysK CHAP, lysostaphin M23, and ALE-1 CBD domains reduces resistant strain development while maintaining high antibacterial activity.

Formula I diamides inhibit N-acetylglucosaminidase, blocking peptidoglycan recycling to prevent antibiotic resistance development.

STP-1 bacteriophage targets Salmonella Typhimurium via tail fiber binding, resolving antibiotic resistance and preserving beneficial microbiome integrity.

Pre-coating silver nanoplates with stabilizers prevents shape degradation during concentration, enabling high optical density solutions.

Surfactants stabilize the pH of an eyelid scrub composition between 5.5 and 7.5, eliminating eye irritation from traditional adjusters.

Citrate and iodide compositions trigger C. difficile spore germination to the vegetative state for enhanced antimicrobial susceptibility.

Bacteroides thetaiotaomicron strain BT2013 restores intestinal barrier integrity and reduces tissue damage by downregulating pro-inflammatory genes.

A five-gene biomarker signature detects active tuberculosis in blood samples using host gene expression analysis.

Segmented antibody design targets conserved IsdA and IsdB epitopes, overcoming previous vaccine failures by blocking heme acquisition.